More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we'll focus further on studies presented at the 2020 ASH Annual Meeting &amp; Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.</p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll focus further on studies presented at the 2020 ASH Annual Meeting &amp; Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.</span></p>